C165H178N28O7 — CID 162243864
1-cyclohexyl-2-[6-[5-(piperidin-4-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;2-[6-[5-(dimethylamino)-3-pyridinyl]isoquinolin-3-yl]-1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]ethanone;1-(4-methylphenyl)-2-[6-[5-[(1-methylpiperidin-4-yl)amino]-3-pyridinyl]isoquinolin-3-yl]ethanone;1-(4-methylphenyl)-2-[6-[5-(piperidin-4-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]-2-[6-[5-(propan-2-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;N-[5-[3-[2-(1-methylpiperidin-4-yl)-2-oxoethyl]isoquinolin-6-yl]-3-pyridinyl]acetamide (PubChem CID 162243864) has the molecular formula C165H178N28O7 and a molecular weight of 2665.43 g/mol. Its IUPAC name is 1-cyclohexyl-2-[6-[5-(piperidin-4-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;2-[6-[5-(dimethylamino)-3-pyridinyl]isoquinolin-3-yl]-1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]ethanone;1-(4-methylphenyl)-2-[6-[5-[(1-methylpiperidin-4-yl)amino]-3-pyridinyl]isoquinolin-3-yl]ethanone;1-(4-methylphenyl)-2-[6-[5-(piperidin-4-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]-2-[6-[5-(propan-2-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;N-[5-[3-[2-(1-methylpiperidin-4-yl)-2-oxoethyl]isoquinolin-6-yl]-3-pyridinyl]acetamide.
| Compound Name | 1-cyclohexyl-2-[6-[5-(piperidin-4-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;2-[6-[5-(dimethylamino)-3-pyridinyl]isoquinolin-3-yl]-1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]ethanone;1-(4-methylphenyl)-2-[6-[5-[(1-methylpiperidin-4-yl)amino]-3-pyridinyl]isoquinolin-3-yl]ethanone;1-(4-methylphenyl)-2-[6-[5-(piperidin-4-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]-2-[6-[5-(propan-2-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;N-[5-[3-[2-(1-methylpiperidin-4-yl)-2-oxoethyl]isoquinolin-6-yl]-3-pyridinyl]acetamide |
|---|---|
| PubChem CID | 162243864 |
| Molecular Formula | C165H178N28O7 |
| Molecular Weight | 2665.43 g/mol |
| Exact Mass | 2663.44 |
| IUPAC Name | 1-cyclohexyl-2-[6-[5-(piperidin-4-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;2-[6-[5-(dimethylamino)-3-pyridinyl]isoquinolin-3-yl]-1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]ethanone;1-(4-methylphenyl)-2-[6-[5-[(1-methylpiperidin-4-yl)amino]-3-pyridinyl]isoquinolin-3-yl]ethanone;1-(4-methylphenyl)-2-[6-[5-(piperidin-4-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;1-[2-(4-methylpiperazin-1-yl)-4-pyridinyl]-2-[6-[5-(propan-2-ylamino)-3-pyridinyl]isoquinolin-3-yl]ethanone;N-[5-[3-[2-(1-methylpiperidin-4-yl)-2-oxoethyl]isoquinolin-6-yl]-3-pyridinyl]acetamide |
| SMILES | CC(=O)Nc1cncc(-c2ccc3cnc(CC(=O)C4CCN(C)CC4)cc3c2)c1.CC(C)Nc1cncc(-c2ccc3cnc(CC(=O)c4ccnc(N5CCN(C)CC5)c4)cc3c2)c1.CN1CCN(c2cc(C(=O)Cc3cc4cc(-c5cncc(N(C)C)c5)ccc4cn3)ccn2)CC1.Cc1ccc(C(=O)Cc2cc3cc(-c4cncc(NC5CCN(C)CC5)c4)ccc3cn2)cc1.Cc1ccc(C(=O)Cc2cc3cc(-c4cncc(NC5CCNCC5)c4)ccc3cn2)cc1.O=C(Cc1cc2cc(-c3cncc(NC4CCNCC4)c3)ccc2cn1)C1CCCCC1 |
| InChI | InChI=1S/C29H32N6O.C29H30N4O.C28H30N6O.C28H28N4O.C27H32N4O.C24H26N4O2/c1-20(2)33-27-14-25(17-30-19-27)21-4-5-23-18-32-26(13-24(23)12-21)16-28(36)22-6-7-31-29(15-22)35-10-8-34(3)9-11-35;1-20-3-5-21(6-4-20)29(34)16-27-14-24-13-22(7-8-23(24)18-31-27)25-15-28(19-30-17-25)32-26-9-11-33(2)12-10-26;1-32(2)26-14-24(17-29-19-26)20-4-5-22-18-31-25(13-23(22)12-20)16-27(35)21-6-7-30-28(15-21)34-10-8-33(3)9-11-34;1-19-2-4-20(5-3-19)28(33)15-26-13-23-12-21(6-7-22(23)17-31-26)24-14-27(18-30-16-24)32-25-8-10-29-11-9-25;32-27(19-4-2-1-3-5-19)15-25-13-22-12-20(6-7-21(22)17-30-25)23-14-26(18-29-16-23)31-24-8-10-28-11-9-24;1-16(29)27-23-11-21(13-25-15-23)18-3-4-19-14-26-22(10-20(19)9-18)12-24(30)17-5-7-28(2)8-6-17/h4-7,12-15,17-20,33H,8-11,16H2,1-3H3;3-8,13-15,17-19,26,32H,9-12,16H2,1-2H3;4-7,12-15,17-19H,8-11,16H2,1-3H3;2-7,12-14,16-18,25,29,32H,8-11,15H2,1H3;6-7,12-14,16-19,24,28,31H,1-5,8-11,15H2;3-4,9-11,13-15,17H,5-8,12H2,1-2H3,(H,27,29) |
| InChIKey | ZXBHZJDREOXYSX-UHFFFAOYSA-N |
| XLogP | 28.22 |
| TPSA | 406.84 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 36 |
| Heavy Atoms | 200 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2665.43 |
| LogP ≤ 5 | 28.22 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 34 |